Monica M.
- Country
- Spain
- Department
- Endocrinology
Research Overview
- Long-Term Extension Study of Imeroprubart in Adult Patients With Graves' Disease
- Phase 2b Randomized Double-Mask Placebo-Controlled Trial of Linsitinib in Active Moderate to Severe Thyroid Eye Disease
- Long-term Safety Evaluation of Octreotide Hydrochloride Subcutaneous Depot (CAM2029) in Patients with Acromegaly: A Phase 3, Open-label, Single-arm, Multicenter Study
Data & Insights
Has run more than one trial at 100 of 110 partner sites.
Specializations
Ocular Disease Expertise
This investigator specializes in the treatment and research of Thyroid Eye Disease (TED), with particular focus on managing moderate to severe manifestations of this condition.
- Orbital inflammatory disorders
- Proptosis management
- Ocular surface disease
Their work involves evaluating novel therapeutic approaches for patients with active TED symptoms.
Endocrine Ophthalmology
The investigator's research centers on the intersection of endocrine disorders and ocular complications, with emphasis on innovative treatment modalities.
- Thyroid-related eye disorders
- Orbital inflammation
- Visual function preservation
Their expertise extends to studying targeted therapies for endocrine-related eye conditions.
Clinical Innovation
The investigator focuses on evaluating novel therapeutic compounds for ocular conditions, particularly in the context of moderate to severe eye disease.
- Treatment response assessment
- Long-term disease management
- Clinical outcomes evaluation
Their work includes investigating new treatment options for patients with progressive eye conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.